Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article.

Source:http://linkedlifedata.com/resource/pubmed/id/19344224

Download in:

View as

General Info

PMID
19344224